CDKN2A and cancer: p53 is frequently inactivated in cancer, which disables the p53-dependent tumor suppressor activity of ARF but leaves ARF available to interact with a variety of other proteins, including topoisomerase I (topo I) [9], [10], an essential enzyme that relaxes DNA supercoils during DNA synthesis [11], [12].